Pancreatic Cancer Research

ResearcherBeth Israel Deaconess Medical CenterActive in the last 2 years

Valerie Marie Weaver

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-4786-6752; OpenAlex author ID A5022114303; NIH RePORTER profile ID 6896322. Sources: funder_awards.

Their work

Papers
8 (first author 0, last author 2)
Trials
0
Grants
3
Labs led
1
Collaborators
43
Papers, trials and grants by year

2013: 1 grant · 2014: 1 grant · 2015: none · 2016: 1 paper · 2017: none · 2018: 1 paper · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: 2 papers · 2025: 2 papers · 2026: 1 paper, 1 grant

Papers 8

  1. Inactivation of CDKN2AARF Promotes p53-Independent Remodeling of the PDAC Tumor Microenvironment. Co-author DOI 10.1158/0008-5472.can-25-1969↗
  2. A STAT3/integrin axis accelerates pancreatic cancer initiation and progression. Co-author DOI 10.1016/j.celrep.2025.116010↗
  3. Pancreatic Cancer Progression Involves Increased Lysyl Oxidase-Mediated Collagen Cross-Links as Part of the Desmoplastic Reaction. Co-author DOI 10.1021/acs.biochem.5c00125↗
  4. Author Correction: Genotype tunes pancreatic ductal adenocarcinoma tissue tension to induce matricellular fibrosis and tumor progression. Last author DOI 10.1038/s41591-023-02694-w↗
  5. nSMase2-mediated exosome secretion shapes the tumor microenvironment to immunologically support pancreatic cancer Co-author DOI 10.1101/2024.09.23.614610↗
  6. Pancreatic ductal adenocarcinoma progression is restrained by stromal matrix. Co-author DOI 10.1172/jci136760↗
  7. Compartment resolved proteomics reveals a dynamic matrisome in a biomechanically driven model of pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.regen.2018.03.002↗
  8. Genotype tunes pancreatic ductal adenocarcinoma tissue tension to induce matricellular fibrosis and tumor progression. Last author DOI 10.1038/nm.4082↗

Grants 3

  1. Antidepressant regulation of PDAC U01CA300847↗
  2. Role of Fibroblasts, Myeloid Cells and Matrix in PDAC U01CA151925↗
  3. Interplay between tension and inflammation in pancreatic tumor progression AWARD pancan:2013-valerie-weaver-phd-interplay-between-tension-and-inflammati

Closest collaborators

The 25 strongest of 43 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Sarah Monica Knox · 1 shared grant, 2026 · strength 1.26
  2. Kirk Charles Hansen · 4 shared papers, 2016–2025 · strength 0.55
  3. Alex Barrett · 3 shared papers, 2016–2025 · strength 0.45
  4. Laura DeLong Wood · 3 shared papers, 2016–2026 · strength 0.43
  5. Grace Kim · 3 shared papers, 2016–2024 · strength 0.35
  6. Matthias Hebrok · 3 shared papers, 2016–2024 · strength 0.35
  7. Raghu Kalluri · 2 shared papers, 1 shared grant, 2014–2024 · strength 0.35
  8. Eric Andrew Collisson · 3 shared papers, 2016–2024 · strength 0.29
  9. Todd M. Pitts · 1 shared paper, 2025 · strength 0.25
  10. Wells A. Messersmith · 1 shared paper, 2025 · strength 0.25
  11. Jen Jen Yeh · 2 shared papers, 2020–2024 · strength 0.23
  12. Dmitri Petrov · 1 shared paper, 2026 · strength 0.23
  13. Sohinee Bhattacharyya · 1 shared paper, 2026 · strength 0.23
  14. Sofia Ferreira · 1 shared paper, 2026 · strength 0.23
  15. Brittany M. Flowers · 1 shared paper, 2026 · strength 0.23
  16. Ghmkin Hassan · 1 shared paper, 2026 · strength 0.23
  17. Mara H. Sherman · 1 shared paper, 2026 · strength 0.23
  18. Andrew J. Aguirre · 1 shared paper, 2026 · strength 0.23
  19. Laura D Attardi · 1 shared paper, 2026 · strength 0.23
  20. Monte Meier Winslow · 1 shared paper, 2026 · strength 0.23
  21. Hanane Laklai · 2 shared papers, 2016–2024 · strength 0.20
  22. Nilotpal Roy · 2 shared papers, 2016–2024 · strength 0.20
  23. Harold L. Moses · 2 shared papers, 2016–2024 · strength 0.20
  24. Julia Sidenius Johansen · 2 shared papers, 2016–2024 · strength 0.20
  25. Christine A. Iacobuzio–Donahue · 2 shared papers, 2016–2024 · strength 0.20

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.